Impact of switching from zidovudine to tenofovir disoproxil fumarate on bone mineral density and markers of bone metabolism in virologically suppressed HIV-1 infected patients; a substudy of the PREPARE study

Authored by: Cotter AG, Vrouenraets S. M. E., Brady JJ, Wit F. W., Fux Christoph A., Furrer H., Brinkman K., Sabin C. A., Reiss Peter, Mallon Patrick, PREPARE investigators
In: The Journal of Clinical Endocrinology & Metabolism, 2013, Apr;98(4):1659-66.